Will Rodgers competes on the NASCAR circuit, despite managing an underlying liver condition. As a young child, Rodgers was diagnosed with primary sclerosing cholangitis (PSC), a chronic liver disease caused by progressive inflammation and scarring of the bile ducts of the liver. While he’s been living healthy for over 20 years, going through that experience, and knowing he could be a positive influence for liver health, led him to start The Will Rodgers Liver Foundation. Currently in the United States, one in 10 people are affected by liver disease, and over 2.4 million Americans are living with hepatitis C (HCV). According to the American Liver Foundation, about 40% of adults in the U.S. living with hepatitis C may not know it. The Foundation provides an interactive environment at race events and select community locations to encourage liver health. Through Rodgers’ collaboration with OraSure Technologies, individuals are provided with free HCV testing from CLIA-waived healthcare professionals using the rapid point-of-care OraQuick HCV Rapid Antibody Test, which allows them to receive results in as little as 20 minutes with a simple finger prick, educational materials and resources to take the next step for those with liver health needs.